on behalf of the ADDITION-Cambridge study team BACKGROUND/OBJECTIVES: A healthy diet is an integral component of successful diabetes management. However, the comparative importance of adopting a healthy diet for cardiovascular risk factor reduction over and above medication use among newly diagnosed diabetes patients remains unclear. SUBJECTS/METHODS: We computed a dietary score consistent with American Diabetes Association and Diabetes UK recommendations in 574 newly diagnosed diabetes patients by summing standardised values for the intake of total energy, saturated fat, sodium, fibre and plasma vitamin C. In linear regression analyses, stratified by cardio-protective medication use (yes/ no), we quantified the comparative longitudinal associations of baseline diet and change in diet over 1 year with change in blood pressure, HbA 1c and lipids. RESULTS: Baseline diet was generally not predictive of change in cardiovascular risk factor levels at 1 year. In contrast, dietary change over 1 year among patients prescribed and not prescribed cardio-protective medication after baseline was associated with comparative (p-interaction all ⩾ 0.95) reductions in diastolic blood pressure (−2.38 vs − 2.93 mm Hg, respectively) and triglycerides (−0.31 vs − 0.21 mmol/l, respectively), independent of potential confounding factors and change from baseline to follow-up in physical activity and smoking status. CONCLUSIONS: Modest dietary change over the first year following diagnosis of diabetes was associated with reductions in blood pressure and triglycerides, over and above the effects of cardio-protective medication. Our findings support the notion that dietary change should be viewed as an integral component of successful diabetes self-management, irrespective of medication use.
INTRODUCTION
Clinical trials and meta-analyses in diabetes patients have shown that adoption of a healthy diet can reduce HbA 1c levels by as much as 2.9% within 3-6 months, 1,2 low-density lipoprotein (LDL) cholesterol by 0.23 mmol/l 2 and significantly reduce blood pressure. 3 Therefore, in addition to medication use, dietary change is recommended as an integral component in the multifactorial treatment strategy for the successful management of diabetes. 4 Nevertheless, many individuals with diabetes struggle to adhere to dietary recommendations, meaning that suboptimal cardiovascular risk factor levels are frequently observed. Dietary non-adherence therefore remains an important area of clinical concern.
Observational studies among individuals with diabetes have shown adherence to be significantly lower for diet 5 than for oral medication use. 6 In a literature review of the most common causes of therapeutic non-adherence, Jin et al. 7 identified patients' beliefs that a therapy would be effective or would provide health benefits as being strongly related to adherence. Consequently, if patients believe that changing their diet has few health benefits and is therefore unimportant, this may explain, in part, dietary non-adherence. Indeed, a number of qualitative studies have shown that diabetes patients believe diet to be less important than medication for good diabetes self-management. 7, 8 Although several landmark trials have demonstrated the importance of dietary change for the prevention of diabetes, 9 little evidence exists demonstrating the comparative benefit of dietary change over and above medication in patients with diabetes.
Using data from a pragmatic trial of intensive, multifactorial treatment among individuals with screen-detected type 2 diabetes (ADDITION-Cambridge), we prospectively examined whether dietary changes consistent with current American Diabetes Association and Diabetes UK guidelines 10, 11 are associated with reductions in cardiovascular risk factors over and above the prescription of cardio-protective medications in the first year after diagnosis of diabetes.
MATERIALS AND METHODS
This study was a secondary analysis of data from participants in the ADDITION-Cambridge study, a detailed description of which has been reported elsewhere. 12 In brief, ADDITION-Cambridge started recruitment in 2001 and consists of two phases: (1) a stepwise screening programme for type two diabetes, and (2) a cluster randomised trial of intensive multifactorial treatment among those found to have diabetes. Individuals were eligible for invitation to the screening phase of the study if they were registered with one of 49 participating general practice surgeries based in the Eastern region of England, UK, were aged 40-69 years, were not known to have diabetes and had a diabetes risk score corresponding to the top 25% of the population distribution. 13 Exclusion criteria included pregnancy, lactation, a psychiatric illness that might invalidate informed consent, or an illness with a likely prognosis of o 1 year. In total, 33 539 eligible individuals were invited to take part in the screening programme. Of these, 867 individuals were found to have diabetes (World Health Organization criteria 14 ) and agreed to participate in the treatment trial. Individuals were treated according to the group to which their practice was allocated: routine care or intensive multifactorial treatment. Individuals allocated to routine care received treatment in accordance with current UK national guidelines for diabetes management. [15] [16] [17] Individuals receiving intensive treatment were given lifestyle advice concerning diet, physical activity, medication adherence, cessation of smoking and supporting educational materials. In addition, general practitioners (GPs) were encouraged to introduce a stepwise target-led drug treatment regime to reduce hyperglycaemia, hypertension and hyperlipidaemia. 12, 18 All participants gave written informed consent, and the study was approved by the Eastern Multi-Centre Research Ethics Committee (reference number: 02/5/54).
Assessment of metabolic risk factors, diet and plasma vitamin C Baseline assessment, which was conducted following diagnosis of diabetes by an oral glucose tolerance test, and 1-year health assessments of the ADDITION-Cambridge participants included physiological and anthropometric measurements taken by trained staff following standard operating procedures and completion of self-report questionnaires.
Blood pressure was calculated as the mean of three measurements performed after 10 min of rest with participants seated with a cuff placed on the predominant arm at the level of the heart, using an automatic sphygmomanometer (Omron M4, Milton Keynes, UK). Body weight and height were measured in light clothing and without shoes using a scale and a fixed rigid stadiometer (SECA, Birmingham, UK), respectively. Waist circumference was calculated as the average of two measurements taken halfway between the lowest point of the rib cage and the anterior superior iliac crests while standing. HbA 1c was measured in venous samples using an ion-exchange high-performance liquid chromatography method (Tosoh Bioscience, Redditch, UK). Serum total cholesterol, high-density lipoprotein (HDL) and LDL cholesterol and triglycerides were measured on non-fasted samples using enzymatic techniques (Dade Behring Dimension analyser, Newark, NJ, USA). Plasma vitamin C was measured with a Fluoroskan Ascent FL fluorometer (Thermo Scientific, Loughborough, UK) within 2 months of sampling. Standardised self-report questionnaires were used to collect information on socio-demographic characteristics. Physical activity energy expenditure was assessed using the validated EPICNorfolk physical activity questionnaire. 19 Medication prescription at baseline and 1-year follow-up was assessed using a self-report questionnaire adapted from the Aberdeen Health Service Research Unit questionnaire, as previously described. 12 Respondents were asked to note: medication name, strength, dosage form (for example, tablets, injection, ointment and so on), number of times daily they use the medication, number of weeks ago they started using the medication and how many weeks ago they stopped using the medication. Respondents were also asked to record the medications used on an occasional basis with similar questions.
A previously validated 130-item semiquantitative food frequency questionnaire (FFQ) 20 was used to assess dietary intake for the preceding 12 months. For each food item, participants were asked to indicate their habitual consumption from nine frequency categories, ranging from 'never or less than once per month' to 'six or more times per day'. Upon completion, the FFQ was checked by trained staff to ensure that all lines of the questionnaire were completed. Food and nutrient intakes were calculated using the Compositional Analyses from Frequency Estimates programme, 21 an in-house programme developed for use in the EPICNorfolk study.
Derivation and calculation of the dietary score
We constructed a dietary score for baseline (baseline dietary score) and follow-up (change in dietary score) on the basis of dietary recommendations by the American Diabetes Association 11 and Diabetes UK 10 for adults with type 2 diabetes. Because foods and nutrients are not consumed in isolation, use of a 'diet quality' score helps minimise confounding by other foods and nutrients, increases contrast between exposure groups compared with analyses based on single nutrients and a dietary pattern might be easier for individuals to interpret or translate into actual diets. 22 The dietary factors identified to be consistent across recommendations included a reduction in energy intake, an increase in fibre intake, a reduction in saturated fat intake, reduced sodium intake and an increased intake of fruits and vegetables. Although specific quantities of intake are specified for several dietary factors (that is, ⩽ 10% of total energy intake from saturated fat and o2300 mg/day of sodium), we used all dietary data in its continuous form as dietary intake assessed by FFQ is less suitable for assessing absolute quantity of intake 23 than it is for assessing relative intake that is, dietary change. 24 Also, continuous data provide greater study power than dichotomised data for detecting associations. 25 A dietary score was computed, combining the intake of energy, saturated fat, sodium, fibre and plasma vitamin C (as an objective biomarker of fruit and vegetable intake 26 ). We standardised individual baseline dietary variables (that is, z-scores were computed: z = (value − mean)/s.d.) using sex-specific baseline means and s.d. from which the follow-up dietary variables were also standardised. Use of a common mean and s.d. for standardised variables at two time points ensures that changes in the score are not removed, as happens when standardising within time points. Next, the baseline and follow-up z-scores were summed after inverting values for the intake of energy, saturated fat and sodium so that increases in the dietary score reflect higher intakes of fibre and vitamin C and lower intakes of energy, saturated fat and sodium. Finally, we divided the dietary scores by the number of individual variables included (that is, five). Change in the dietary score was calculated by subtracting the followup from the baseline dietary score.
On the basis of our sample, each s. Of the 867 participants, we excluded those with missing baseline or follow-up data for the dietary score (n = 85), cardiovascular risk factors (n = 174), potential confounders (n = 22) and those with missing data on medication prescription (n = 12). The final sample for this analysis was n = 574 participants.
Statistical analysis
For this analysis, data were treated as a cohort and not analysed by trial arm as behavioural interventions rarely achieve large differences between arms and an analysis by trial arm would therefore amount to a test of the effect of the behaviour change intervention and not a test of the benefits of behaviour change.
Because men and women tend to differ in terms of dietary intake, descriptive characteristics were summarised separately by sex, using means with s.d. or frequencies. Independent samples' t-tests or χ 2-tests were used to examine whether there were any differences in participant characteristics between those with and those without missing data for this analysis. Paired samples t-tests or Wilcoxon signed-rank tests were used to examine differences in values of continuous variables between baseline and 1 year.
We first used multivariate linear regression analysis to examine the association of the baseline dietary score with changes in cardiovascular risk factor levels (systolic and diastolic blood pressure, HbA 1c , triglycerides, total cholesterol and LDL and HDL cholesterol) over 1 year, stratified by medication prescription for hypertension, glucose or dyslipidaemia at 1 year (that is, those prescribed medication for hypertension, glucose or dyslipidaemia at 1 year were compared with those who were not prescribed these medications). Modelling the association of the baseline dietary score with change between baseline and 1 year in cardiovascular risk factors enables examination of whether eating a 'healthier' diet to begin with relates to a more advantageous change in cardiovascular risk profile over the 1 year following diagnosis of diabetes. We formally assessed for potential effect modification by randomisation group and sex by entering cross-product terms (that is, diet randomisation group) with main effects in the multivariate models. After confirming no effect modification by randomisation group or sex (all P-values ⩾ 0.05), all subsequent analyses were examined adjusted for randomisation group and sex. Models were additionally adjusted for age, occupational socio-economic class, baseline use of anti-hypertensive medications, glucose-lowering medications or lipid-lowering medications (as appropriate), the baseline cardiovascular risk variable under study, and baseline and change from baseline for physical activity and smoking status. Next, multivariate linear regression was used to examine the association of change in dietary score with change in cardiovascular risk factor levels over 1 year, again stratified by prescription for anti-hypertensive medications, glucose-lowering medications or lipid-lowering medications (as appro
All statistical analyses were performed using Stata/SE 13.1 (Stata-Corp, College Station, TX, USA). Table 1 shows the anthropometric and metabolic characteristics of participants at baseline and 1 year, stratified by sex. The mean (s.d.) age of participants was 61.1 (7.0) years. The majority of participants were men (63.6%); 69.7% of the cohort were obese (body mass index ⩾ 30.0 kg/m 2 ). Participants with missing data at baseline or at 1 year (n = 293) had similar anthropometric, metabolic and dietary characteristics to those with complete data for all variables (all P-values ⩾ 0.11), except for body mass index which was lower among those with complete data (P o0.001).
RESULTS
Among men and women, mean waist circumference, systolic and diastolic blood pressure, triglycerides, total cholesterol, LDL cholesterol and HbA 1c levels were lower at 1 year than at baseline, whereas HDL cholesterol levels were higher. Self-reported total energy intake decreased from 2029 at baseline to 1738 Kcal/d at 1 year among men, and from 1770 to 1636 Kcal/d among women. Percentage of energy from saturated fat decreased among men and women by 1.6% and 1.0%, respectively. Sodium intake was lower at 1 year among men, but not women, whereas plasma vitamin C levels were higher at 1 year among women but not men. Self-reported physical activity energy expenditure remained unchanged between baseline and 1 year. There were significant increases in the prescription of cardio-protective medications between baseline and 1 year.
The results of the analysis examining the association between baseline dietary score and change in cardiovascular risk factor levels over 1 year, stratified by medication prescription at 1 year, are shown in Table 2 . Following adjustment for potential confounding factors and baseline cardiovascular risk factors (as appropriate), no significant associations were found, except between the baseline dietary score and HbA 1c among individuals prescribed glucose-lowering medication at 1 year (β: − 0.30, 95% CI: − 0.56, − 0.04).
The results of the analysis examining the association between change in dietary score and change in cardiovascular risk factor levels between baseline and 1 year are shown in Table 2 . Among participants not prescribed anti-hypertensive medications, glucose-lowering medications or lipid-lowering medications, respectively, improvements in the dietary score were associated with significant reductions in systolic blood pressure (β: − 5.53, The association between change in dietary score and change in diastolic blood pressure, triglycerides and total cholesterol were comparable for individuals who were prescribed and not prescribed medication (p-interaction: 0.95, 0.97 and 0.74, respectively). Individuals who were not prescribed glucose-lowering medication experienced greater reductions in HbA 1c compared with those prescribed medication, and the difference between groups was significant (p-interaction: 0.03). Although the magnitude of the association between changes in dietary score and change in systolic blood pressure appeared to be most pronounced for those not prescribed anti-hypertensive medications, the interaction term was not statistically significant (p-interaction: 0.62). Change in the dietary score was not associated with HDL or LDL cholesterol levels.
DISCUSSION
Following diagnosis of diabetes, dietary changes consistent with current American Diabetes Association and Diabetes UK recommendations 10, 11 are associated with reductions in blood pressure, HbA 1c , triglycerides and total cholesterol. Moreover, the changes for diastolic blood pressure and triglycerides are similar in magnitude among individuals prescribed and those not prescribed medication, independent of age, sex, socio-economic status and baseline and change from baseline for physical activity and smoking status. To our knowledge, this is the first study demonstrating that dietary changes consistent with current recommendations in the first year following diagnosis of diabetes are equally important for individuals who have been prescribed medication for blood pressure and lipid control as for those who have not, thereby highlighting the need for health-care providers to improve patient's understanding of the complimentary role of a healthy diet for the successful management of diabetes.
Previous longitudinal studies have reported beneficial associations between dietary change and a number of cardiovascular risk factor levels including triglycerides, insulin and HDL cholestrol among healthy individuals and those with type 2 diabetes. However, the relative importance of diet for cardiovascular risk control over and above the benefits of medication remains largely unknown. In the Early Activity in Diabetes (Early Actid) randomised trial, 27 dietary intervention among people with newly diagnosed diabetes was associated with a 0.28% (P = 0.005) lower HbA 1c level at 6 months compared with a control group. Insulin resistance also improved in the dietary intervention group, although blood pressure remained unchanged in all groups throughout the study. In a small trial among individuals who were taking glucoselowering medication for elevated HbA 1c levels (>7%) (the Lifestyle Over and Above Drugs in Diabetes controlled trial), dietary advice for 6 months was associated with reductions in HbA 1c of 0.4% (95% CI: 0.1, 0.7%). 28 This is in contrast to our finding of no association between dietary change and HbA 1c levels in those prescribed glucose-lowering medication. This difference is likely explained by the fact that the diabetes patients in our study were newly diagnosed, whereas those in the Lifestyle Over and Above Drugs in Diabetes controlled trial had diabetes for ⩾ 9 months and had poor glycaemic control despite optimised drug treatment. In a study which examined the relationship between lifestyle Models adjusted for age, randomisation group, sex, occupational socio-economic class, baseline prescription for anti-hypertensive medications, glucose-lowering medications or lipidlowering medications (as appropriate), the baseline cardiovascular risk factor under study and baseline and change from baseline for PAEE and smoking status. Models adjusted as before but also including baseline diet.
c P-interaction corresponds to the analysis for ΔDiet.
modification and cardiovascular risk factor levels among patients taking and not taking glucose-lowering medications, Barnard et al. 29 showed lifestyle modification to be effective for reducing fasting glucose, systolic and diastolic blood pressure and for improving overall lipid profiles. Similar to our findings, the smallest reduction in fasting glucose was observed among patients taking glucose-lowering medication.
To put our findings in perspective, dietary changes (per s.d. increase) of the magnitude observed in our study could be achieved by using half a teaspoon less of salt during cooking and by substituting a chocolate bar (80 g) with a piece of fruit on a daily basis. Although such changes may appear modest, assuming causality, the observed benefits to blood pressure and lipid levels, which are additive to prescribed medication use, would be important for improved cardiovascular risk management. For example, a decrease in systolic blood pressure of just 2.5 mm Hg would be expected to reduce the risk for any cardiovascular end point related to diabetes by~4%. 30 There are several strengths of our study, including the standardised anthropometric and clinical measurements taken at baseline and 1 year by trained staff and adjustment for baseline cardiovascular risk factors and changes in important potential confounding factors over 1 year (that is, physical activity and smoking status). Four of the five dietary variables included in our dietary score were assessed by self-report using a FFQ. When assessing dietary change, the FFQ has been shown to be comparable to using multiple-day diet records. 24 In addition, the change observed in plasma vitamin C levels, an objective biomarker of fruit and vegetable intake, 26 provides further indication that dietary behaviour did improve over the course of 1 year. By comparing the associations from analyses of the baseline dietary score with those of changes in the dietary score with parallel changes in cardiovascular risk factors, we have been able to demonstrate that it is dietary change that is associated with improvements in cardiovascular risk factor levels. Finally, use of a 'diet quality' score minimises confounding by other foods and nutrients, increases contrast between exposure groups and might be easier for individuals to interpret or translate into actual diets. 22 Several potential limitations of our study also need to be considered. First, as dietary intake was assessed by self-report and study participants had received information about a healthy diet, we cannot rule out the possibility that participants may have over-reported their intake of healthy foods and under-reported unhealthy foods owing to social desirability bias. Second, we assessed medication prescription and not medication use per se. Third, as participants included in the study had a lower mean body mass index than those excluded owing to missing data, among whom dietary change would be expected to be most beneficial, the associations that we observed between the dietary change score and cardiovascular risk factors would likely be biased towards the null. Fourth, our study population is predominantly of European-Caucasian origin and middle aged, and, as such, the generalizability of our findings to other populations may be limited. Finally, although we have adjusted for many potential confounding factors, we cannot exclude the possibility of residual confounding or confounding by unmeasured factors.
In conclusion, modest dietary changes in the year following diagnosis of diabetes were associated with reductions in blood pressure and triglycerides over and above the prescription of cardio-protective medication. Our findings support the notion that dietary change should be viewed as an integral component of successful diabetes management, irrespective of prescription for cardio-protective medications. Further research is needed to establish whether the relative benefits of dietary change remain or become even more pronounced with longer durations of follow-up.
